Skip to content
value.today

BirchBioMed Inc.

Total raised
$9 M
3 rounds on record
Latest round
$2 M
Jun 2025
First round on record
May 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BirchBioMed Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2025$2 MNo. 3$2 to $10 million

BirchBioMed Inc.: Raise no. 3, Jun 2025

Investors in this round

18 investors had bought by the notice of Oct 1, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in British Columbia, Canada

People named in the notice

  • Carlos Camozzi · Executive Officer
  • Herve Girsault · Executive Officer
  • John Verbeck · Executive Officer
  • Mark Miller · Executive Officer, Director, Promoter
  • Susan Elliott · Executive Officer, Director, Promoter
  • Charles Ellis · Director
  • Joseph Sardano · Director
  • Teresa Bair · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Oct 1, 2025. Read the notice at the SEC.

debt, optionsSEC
Jun 2016$1 MNo. 2Under $2 million

BirchBioMed Inc.: Raise no. 2, Jun 2016

Investors in this round

20 investors had bought by the notice of Sep 20, 2017: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $10 M offered; $9 M still to sell
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$800,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in British Columbia, Canada

People named in the notice

  • Mark S. Miller · Executive Officer, Director, Promoter
  • Richard J. Shaw · Executive Officer
  • Ryan V. Hartwell · Executive Officer, Director, Promoter
  • Susan M. Elliott · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in AZ, FL, NY, TX, UT

Remarks in the notice

  • On fees: “Cash Commission is equal to 8% of the total offering amount sold to U.S. investors introduced by Maxim and 4% for investors introduced by BirchBioMed Inc. Payment of full commission is contingent on amount sold.”

Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Sep 20, 2017. Read the notice at the SEC.

equitySEC
May 2016$5 MNo. 1$2 to $10 million

BirchBioMed Inc.: Raise no. 1, May 2016

Investors in this round

97 investors had bought by the notice of Feb 5, 2020: 97 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$59,200
Finders' fees
none
Paid to its own people
$1,719,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in British Columbia, Canada

People named in the notice

  • Jon M. Verbeck · Executive Officer
  • Mark S. Miller · Executive Officer, Director, Promoter
  • Ryan V. Hartwell · Executive Officer, Director, Promoter
  • Susan M. Elliott · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in AZ, CA, FL, IN, MN, NH, NY, OH, PA, TX, UT

Remarks in the notice

  • On fees: “Maxim Group received these fees from prior investments but has waived any commissions or finders fees for this offering going forward.”

Signed by Mark S. Miller, Chief Executive Officer. Newest notice filed Feb 5, 2020 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BirchBioMed Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2025).

    SEC Form D · Oct 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of BirchBioMed Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BirchBioMed Inc.
NameRoleNamed in
Carlos CamozziExecutive officerOct 2025
Herve GirsaultExecutive officerOct 2025
John VerbeckExecutive officerOct 2025
Mark MillerExecutive officerOct 2025
Susan ElliottExecutive officerOct 2025
Jon M. VerbeckExecutive officerFeb 2020
Mark S. MillerExecutive officerFeb 2020
Ryan V. HartwellExecutive officerFeb 2020
Susan M. ElliottExecutive officerFeb 2020
Richard J. ShawExecutive officerFeb 2019
Charles EllisDirectorOct 2025
Joseph SardanoDirectorOct 2025
Mark MillerDirectorOct 2025
Susan ElliottDirectorOct 2025
Teresa BairDirectorOct 2025
Mark S. MillerDirectorFeb 2020
Ryan V. HartwellDirectorFeb 2020
Susan M. ElliottDirectorFeb 2020
Mark MillerPromoterOct 2025
Susan ElliottPromoterOct 2025
Mark S. MillerPromoterFeb 2020
Ryan V. HartwellPromoterFeb 2020
Susan M. ElliottPromoterFeb 2020